06 septiembre 2024

NUEVA TERAPIA CON TARLATAMAB ( IMDELLTRA BY AMGEN ) PARA TRATAR EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EXTENSO QUE NO HA RESPONDIDO O HA DEJADO DE RESPONDER A LA QUIMIOTERAPIA ... OFRECIDA EN EL CENTRO ONCOLÓGICO MUSC HOLLINGS .

 


A New Type Of Treatment For SMALL CELL LUNG CANCER Is Now Offered At MUSC Hollings Cancer Center, And Oncologist Mariam Alexander, M.D., Ph.D., Is Excited Not Only For What This Means For Her Patients But What It Portends For Treatment Of Solid Tumors Of All Types .

The U.S. Food and Drug Administration Approved TARLATAMAB in May For patients whose Extensive SMALL CELL LUNG CANCER Has Not Responded Or Stopped Responding To Chemotherapy . ...